PETMED EXPRESS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
PETMED EXPRESS, INC. (PETS) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 753.00 thousand shares as of 2023-03-31, per its 10-K/A filed 2024-04-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2024-04-15
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 753.00K shares.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 771.00K shares.
- 2021-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 160.00K shares.
- 2020-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 183.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number as first filed |
|---|---|---|
| 2023-03-31 | 753.00K shares 10-K/A · filed 2024-04-15 | |
| 2022-03-31 | 771.00K shares 10-K/A · filed 2024-04-15 | |
| 2021-03-31 | 160.00K shares 10-K · filed 2022-05-24 | |
| 2020-03-31 | 183.00K shares 10-K · filed 2021-05-25 | |
| 2019-03-31 | 150.00K shares 10-K · filed 2020-05-26 | |
| 2018-03-31 | 193.00K shares 10-K · filed 2019-05-28 | 193.00 shares 10-K · filed 2018-05-29 |
| 2017-03-31 | 232.00 shares 10-K · filed 2018-05-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS HEALTH Corp (CVS) | United States | $108.783B | 27.06 |